BGPT: Paper Review: Integrin-linked kinase (ILK) and its interactors

Explore by Goal

Quick Explanation Copied

ILK as an adhesome “scaffold/kinase-hybrid”: this 2001 review synthesizes evidence that ILK links integrins to actin via a PINCH–CH-ILKBP/actopaxin/α-parvin–affixin–paxillin network and routes signals to PKB/Akt, GSK-3, β-catenin, AP-1/CREB, Erk, and MLC—while explicitly noting controversy over whether ILK’s kinase activity is necessary for all functions.

Long Explanation

Paper Review (Visual + Skeptical): ILK and its interactors

Journal of Cell Biology • DOI: 10.1083/jcb.200108077 • Published: Nov 05, 2001

What the paper is (and is not)

Type: narrative review synthesizing biochemical, cell biological, and genetic findings on ILK and binding partners.
Key deliverable: a structural/functional map: ILK domain → binding partners → adhesion localization → downstream signaling modules.
Not a single experiment: the review does not provide new quantitative datasets of its own (so “reproducibility” is about whether the cited methods/results were reproducible and broadly consistent).

Figure A — Adhesome wiring diagram (ILK interactors → actin + signaling)

Schematic reconstructed from Table I + the paper’s Figure 1 narrative. Claims about biology are restricted to what’s described in the review.

Skeptical note on evidence

The review emphasizes binding and localization using multiple detection modes (e.g., co-IP/pull-down/2-hybrid), but binding does not automatically imply stoichiometric in vivo complex formation.

Figure B — How many ILK-binding proteins map to each ILK structural region?

Reconstructed from Table I “Target on ILK” categories in the provided paper text.

Count limitation: Table I includes entries with “Not determined”; this chart intentionally includes only explicit target mappings provided in the text.

Figure C — “Kinase activity controversy” as a fork in the mechanistic road

The review explicitly discusses uncertainty about whether ILK’s catalytic activity is directly detectable/required for some functions.

Directly from the review: ILK’s kinase activity is discussed as potentially controversial, with evidence that some mutations in the PH domain (Arg211) and activation loop (Ser343) render the kinase inactive and unable to phosphorylate Akt, while other data (e.g., inability to detect activity in ILK immunoprecipitates) supported indirect regulation. The review concludes the balance “seems to tip” toward ILK being a bona fide kinase but allows kinase-independent functions.

Long-form mechanistic synthesis (what is known vs uncertain)

1) ILK domain architecture is used as the organizing principle

The review states ILK has three structurally distinct regions: N-terminal ANK repeats, a COOH-terminal PH-like motif, and a downstream COOH-terminal region homologous to protein kinase catalytic domains.

Uncertainty: Domain homology does not guarantee catalytic equivalence in all contexts. The review directly acknowledges that some functions might not need catalytic activity.

2) Binding partners: a curated “interactors list” with explicit detection modalities

The review reports that nine distinct ILK-binding proteins had been identified (Table I), including integrins, PINCH, CH-ILKBP/actopaxin/α-parvin, affixin, paxillin, ILKAP, and substrate/regulators implicated for signaling (PKB/Akt and PDK-1).
The review highlights that ILK can form a multicomponent complex with PINCH and CH-ILKBP via two separate domains and that paxillin was not detected in that specific multicomponent complex despite potential ability to bind ILK/CH-ILKBP.

3) Localization to focal/fibrillar adhesions is framed as a two-interaction requirement

The review says ILK localizes to both focal adhesions and fibrillar adhesions, and that localization is mediated by at least two interactions: disrupting PINCH binding impairs localization, and deleting the ILK COOH-terminal domain also abolishes localization.

Blind spot: “Required” does not automatically mean sufficiency; the review itself states PINCH binding is required but not sufficient.

4) Actin anchoring: CH-ILKBP–actopaxin–α-parvin as a primary bridge (with additional candidate routes)

The review presents several lines of evidence that the CH-ILKBP–actopaxin–α-parvin complex can link ILK to actin, including ability to interact with ILK and actin, inhibitory effects of ILK-binding CH2 fragments on stress fibers/shape change, and conservation/phenotypes in a C. elegans homolog context.
It also lists other plausible linkages (PINCH, paxillin via actin-binding proteins, affixin) but explicitly includes at least one “negative detection” (direct affixin–actin interaction not detected in vitro).

5) Signaling: ILK is positioned upstream of Akt, GSK-3, β-catenin, AP-1/CREB, Erk, and MLC phosphorylation

The review states ILK activity is stimulated transiently by ECM and growth factors and is PI3K-dependent, with PI(3,4,5)P3 binding to ILK’s PH-like domain proposed to be involved.
Negative regulation by PTEN and ILKAP is described, and phosphorylation targets include PKB/Akt (Ser473), GSK-3 (Ser9), MLC (Ser18/Thr19), and affixin.
Pathway-level consequences are summarized: inhibition of GSK-3 leading to β-catenin stabilization; AP-1 activation (and its linkage to cyclin D1 and MMP-9 upregulation are described).
Non-conservation caveat: it reports that key signaling hallmarks in mammalian cells (Akt/GSK-3/β-catenin) may not be conserved in Drosophila.

6) Disease framing: PTEN/APC loss and disease-associated ILK upregulation

The review states dysregulation of ILK activity/expression is implicated in oncogenic transformation and tumor models, including contexts involving PTEN and APC and upregulation in cancers such as Ewing sarcoma, advanced prostate cancer, colonic polyposis/colorectal cancers, and diabetic nephropathy/kidney disease glomeruli/podocytes.

Skeptical angle: correlations between ILK expression/activity and disease phenotypes can reflect upstream causes (not just causation). This is a general mechanistic limitation of review-level synthesis.

Modern context check (what later literature adds)

These are not claims replacing the 2001 review; they help assess whether the review’s “kinase controversy” has moved.

Pseudokinase framing (broader kinome perspective): a 2006 review on pseudokinases situates ILK among kinase-like regulatory proteins and emphasizes that catalytic inactivity is not a universal explanation for regulatory function.
ILK “not so pseudo” emphasis: a 2011 Oncogene paper reviews evidence that ILK functions as both protein kinase and adaptor and evaluates the support for kinase activity across cellular contexts.
Functional enzymology support: a 2010 PLoS ONE study reports ILK as a Mn2+-dependent protein kinase regulating GSK-3β phosphorylation, with kinetic behavior measured using recombinant ILK and purified substrates.
Complex composition mapping (PINCH interactome): a 2013 Proteome Science article develops iGEO and validates a core PINCH–ILK–Parvin–RSU1 complex with additional PINCH partners.

Key counterpoints / limitations / blind spots (science-only)

Complex composition vs binding: the review acknowledges cases where a protein binds ILK/CH-ILKBP but is not detected in a specific multicomponent complex (paxillin).
Kinase dependence may be context-dependent: the review highlights both pro-kinase and skeptical evidence and explicitly allows that some ILK functions might not require kinase activity.
Cross-species generalization risk: Drosophila non-conservation is explicitly mentioned, implying that mechanistic models must be tested per organism/context.
Review selection bias: being a synthesis, it can emphasize prominent lines of evidence and may omit weaker/contradictory studies that were less influential at the time (a general review limitation). (No additional citation available beyond the review’s own nature.)

Explore more on BGPT (bespoke next steps)

Author reviews (recommended)

Feedback:

Updated: April 26, 2026